4//SEC Filing
Von Seggern Christopher 4
Accession 0001209191-20-046974
CIK 0001582313other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 6:38 PM ET
Size
5.4 KB
Accession
0001209191-20-046974
Insider Transaction Report
Form 4
Von Seggern Christopher
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-08-17+100,000→ 100,000 totalExercise: $11.27Exp: 2030-08-16→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001821192
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 6:38 PM ET
- Size
- 5.4 KB